
Iovance Biotherapeutics Inc (IOVA) Stock: A Closer Look at the Moving Averages
In the past week, IOVA stock has gone down by -12.92%, with a monthly gain of 3.33% and a quarterly plunge of -46.64%. The volatility
In the past week, IOVA stock has gone down by -12.92%, with a monthly gain of 3.33% and a quarterly plunge of -46.64%. The volatility
The stock price of Iovance Biotherapeutics Inc (NASDAQ: IOVA) has surged by 5.11 when compared to previous closing price of 3.33, but the company has
In the past week, IOVA stock has gone up by 14.71%, with a monthly gain of 2.03% and a quarterly plunge of -43.84%. The volatility
The stock price of Iovance Biotherapeutics Inc (NASDAQ: IOVA) has plunged by -0.33 when compared to previous closing price of 3.07, fool.com reported 2025-04-19 that
Additionally, the 36-month beta value for IOVA is 1.05. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 4
Company’s 36-month beta value is 1.06.Analysts have differing opinions on the stock, with 8 analysts rating it as a “buy,” 4 as “overweight,” 1 as
IOVA has 36-month beta value of 1.01. Analysts have mixed views on the stock, with 8 analysts rating it as a “buy,” 4 as “overweight,”
Iovance Biotherapeutics Inc (NASDAQ: IOVA)’s stock price has soared by 1.84 in relation to previous closing price of 3.54. Nevertheless, the company has seen a
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.